![]() |
|
|
Department of Nutritional Science and Dietetics, University of Nebraska, Lincoln, NE 68583-0806
3To whom correspondence should be addressed.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: stearic acid sterol balance cholesterol absorption hamsters
| INTRODUCTION |
|---|
|
|
|---|
Studies in rats (Feldman et al. 1979a
and 1979b
) have
suggested that dietary 18:0 inhibits cholesterol absorption. A
reduction in cholesterol absorption could lead to changes in sterol
balance and cholesterol turnover. Consequently, the present study was
conducted to examine the role of 18:0 and other common dietary fatty
acids in cholesterol absorption and turnover using the hamster model. A
novel aspect of the study was the use of five experimental diets
differing in only a single fatty acid, which allowed the isolation of
specific metabolic effects of each fatty acid. We chose to focus on
five fatty acids commonly found in the U. S. food supply: palmitic
acid (16:0), stearic acid (18:0), trans fatty acids
(18:1t), cis oleic acid (18:1c) or
linoleic acid (18:2).
| MATERIALS AND METHODS |
|---|
|
|
|---|
Male Syrian hamsters (Charles River, Wilmington, MA) weighing ~70 g were individually housed in polycarbonate cages with a bedding of wood chips. Hamsters were kept in an environmentally controlled room at 25°C with a 12-h light-dark cycle for the duration of the 18-wk experiment. All experimental procedures were approved by the Institutional Animal Care and Use Committee at the University of Nebraska.
Hamsters were fed a modified version of the NIH-07 open-formula,
cereal-based rodent diet (AIN 1977
, Knapka et al. 1974
). We have recently published a more thorough discussion on
the usefulness of the modified NIH-07 diet in hamster studies
(Cai and Carr 1999
). The primary modification was an
increase in total fat from 25 to 150 g/kg diet, with compensatory
decreases in ground corn, ground wheat and wheat middlings (Table 1
). The grains and fish meal used in the modified NIH-07 diets contained
some residual fat and, thus, contributed a minimal amount of fat (~2
g/100 g) to the total diet composition. Cholesterol was also added to
the diets to achieve a concentration of 0.05 g/100 g. The diets were
prepared by Dyets (Bethlehem, PA) using oil blends supplied by our
laboratory. Five experimental diets were made with several different
vegetable oils so that each diet was enriched in a single fatty acid
(Table 2
). Each oil blend was enriched 30% with the fatty acid of interest
above a constant fatty acid background made up of ~10% 16:0, 8%
18:0, 0% 18:1t, 40% 18:1c and 8% 18:2.
|
|
8 and
12. Small amounts of 18:2t isomers were detected in
the hydrogenated soybean oil (<2 g/100 g total fatty acids) and are
listed under "Other fatty acids" in Table 2
The amount of tocopherols in the oil blends was measured by HPLC
(Ueda and Igarashi 1987
). The high 18:2 oil blend
contained the highest amount of tocopherols; therefore,
(+)-
-tocopherol acetate was added to the other oil blends to produce
the same
-tocopherol equivalents in each oil blend.
Experimental design.
Hamsters (n = 64) were randomly divided into five
groups. Each group contained 13 animals except the 18:0 group, which
contained 12 animals. Hamsters were fed for 18 wk and were given free
access to their diets and water supply. Body weights were recorded
bi-weekly and food intake was recorded weekly during the 18-wk
study. Body weight and food intake are expressed as the average of
measurements taken between wk 12 and 18 (Table 3
). We have expressed the data in this manner because a single value for
body weight, food intake and fecal output was needed for calculating
the sterol balance data shown below. We chose to average data from wk
1218 because weekly food intake measurements were not significantly
different during this period and the hamsters were no longer growing.
In addition, fecal output and subsequent fecal lipid analyses were
performed on samples collected during wk 12, whereas plasma cholesterol
measurements were made in samples collected during wk 18. Therefore, we
wanted body weight and food intake to reflect the entire period between
wk 12 and 18.
|
Cholesterol absorption efficiency.
Cholesterol absorption was measured during wk 8 by simultaneous oral
administration of [3H]-ß-sitostanol and
[14C]-cholesterol (Borgström 1968
).
ß-Sitostanol virtually is not absorbed in the intestinal tract of
hamsters (Turley et al. 1994
); thus it serves as a
reference compound for cholesterol absorption. The radiolabeled sterols
were purchased from American Radiolabeled Chemicals (St. Louis, MO).
Hamsters were dosed on two consecutive days with 50 µL vegetable oil
containing ~80 kBq [3H]-ß-sitostanol and 80 kBq
[14C]-cholesterol. They were allowed to ingest the
radioisotope/vegetable oil mixture via eyedropper while still in their
cages, so essentially no stress was incurred during the procedure.
Feces were collected, finely ground and saponified, and total
radioactivity was quantified by scintillation spectrometry as
previously described (Cai and Carr 1999
). Cholesterol
absorption efficiency was calculated as a percentage from the ratio of
the two radiolabels in the dose and feces using the following equation:
Percenage cholesterol absorption = [(14C/3H in dose
-14C/3H in
feces)/(14C/3H in dose)] x 100.
Fecal neutral steroids.
Nonradioactive feces (~50 mg) were extracted into methanol/chloroform
(2:1, v/v) (Folch et al. 1957
) containing 10 mg/L
5
-cholestane as an internal standard. Prior to lipid extraction, the
fecal samples were acidified by adding 0.2 mL of 0.5 mol/L HCl. The
lower phase solvent was evaporated and the samples saponified in 2 mL 1
mol/L methanolic KOH for 1 h at 50°C. After the addition of 2 mL
deionized water, the nonsaponifiable lipids were extracted into 5 mL
hexane. The hexane was evaporated under nitrogen and the steroids
derivatized by adding 100 µL pyridine, followed by 50 µL Sylon BTZ
(Supelco, Bellefonte, PA). The samples were allowed to stand 30 min at
room temperature and the reaction was stopped by placing the samples on
ice. The fecal neutral steroids were quantified by gas chromatography
using a 0.25 mm x 15 m DB-1 capillary column (J & W
Scientific, Folsom, CA) under the following conditions: initial
temperature 190°C for 1 min, increased to 220°C at 3°C/min;
injector temperature, 270°C; flame ionization detector temperature,
300°C; helium carrier gas; and split ratio of 50:1. Sterols of plant
origin were identified but were not included in the analysis. Fecal
"neutral steroids" reported herein refer to the sum of cholesterol,
dihydrocholesterol, coprostan-3-one and coprostan-3-ol.
Fecal bile acids.
Ground feces (~100 mg) were placed in screw-cap tubes with 0.7 mL
deionized water; 10 mL chloroform/methanol (2:1, v/v) was added
according to the method of Folch et al. (1957)
. After 30
min, 2 mL 8.8 g/L KCl was added and mixed, and the sample was
centrifuged at 1000 x g for 15 min to separate
phases. The upper phase containing bile acids was quantitatively
transferred to a clean tube and the lower phase was washed once by
adding fresh upper phase (chloroform/methanol/water, 3:48:47). The
sample was gently mixed and centrifuged as before. The upper phase from
the wash step was added to the upper phase from the first extraction.
An aliquot of upper phase was transferred to a 1-cm diameter round
cuvette and the solvent was evaporated at 50°C under a stream of
nitrogen.
Total bile acids in the cuvette were quantified by first dissolving the
bile acids in 0.1 mL methanol. Exactly 3.5 mL incubation buffer was
added to the samples and mixed. The incubation buffer contained 0.2 mg
ß-NAD (Sigma Chemical, St. Louis, MO) per mL of 0.05 mol/L CAPS
buffer (pH 10.8) and was prepared immediately prior to use. The
background absorbance of the samples was determined at 340 nm. The
reaction was initiated by adding 0.4 mL 3
-hydroxysteroid
dehydrogenase (750 U/L 0.01 mol/L phosphate buffer, pH
7.2). Hydroxysteroid dehydrogenase was purchased from Sigma Chemical.
The samples were incubated at 37°C for 30 min. The absorbance was
read again at 340 nm to determine the concentration of NADH. The
concentration of total bile acids was calculated by the difference of
the two absorbance readings (accounting for the dilution of 0.4 mL
enzyme solution), compared against a calibration curve using cholic
acid standards in methanol.
Dietary lipid absorption.
Dietary lipid absorption was measured as the difference between the
amount of lipid consumed and the amount excreted. Diet and fecal lipids
were extracted from oven-dried samples into chloroform/methanol
(2:1, v/v) according to the method of Folch et al. (1957)
. The extraction solvent was evaporated and the amount of
lipid in the diets and feces was determined gravimetrically. Total
fecal lipid values were adjusted by subtracting out the amount of
neutral steroids present in the feces to more accurately quantify
saponifiable fecal lipids. The absorption of individual fatty acids was
also quantified by determining the fatty acid distribution in fecal
lipids using the same procedure described above for dietary fatty
acids.
Plasma cholesterol.
Blood was collected by cardiac puncture using 10 mL syringes containing
10 mg EDTA as an anticoagulant. Red blood cells were removed by
centrifuging the blood at 1000 x g for 30 min at
4°C. Plasma (~23 mL) was recovered from each hamster. Aprotinin
(1 mg/L) and phenylmethylsulfonyl fluoride (80 mg/L) were added to the
plasma as preservatives. Plasma total cholesterol concentration was
determined enzymatically (Carr et al. 1993
).
Statistical analyses.
Treatment and time effects were statistically analyzed using ANOVA. Differences among treatment groups were assessed by the Tukey multiple comparison procedure. Differences with P < 0.05 were considered significant. Associations between variables were determined by Pearson product moment correlation analysis. All statistical analyses were performed on a personal computer using SigmaStat (SPSS Science, Chicago, IL).
| RESULTS |
|---|
|
|
|---|
Food intake, recorded weekly throughout the study, was not
significantly different among treatment groups at any of the time
points (data not shown). Food intake was highest early in the study
while the hamsters were still growing (5459 g/wk at wk 3), and
decreased to 3742 g/wk by wk 12. Food intake was not significantly
different in any of the treatment groups between wk 12 and 18, and the
mean food intake during this period is shown in Table 3
.
Total dietary lipid absorption (mg/d) was significantly less in the
16:0 and 18:0 groups compared to hamsters fed diets high in
18:1t, 18:1c and 18:2 (Table 4
). When expressed as a percentage of dietary lipid absorbed, total lipid
absorption was ~9394% in all treatment groups except for hamsters
fed the high 18:0 diet, in which lipid absorption efficiency was
significantly less at 89%. Table 4
also shows the absorption of
individual dietary fatty acids. In general, the saturated fatty acids
were absorbed less efficiently than the unsaturated fatty acids in all
treatment groups.
|
|
Daily cholesterol absorption and excretion, normalized to body weight,
is shown in Table 6
. Cholesterol absorption efficiency was significantly reduced in
hamsters fed the high 18:0 diet compared to the other treatment groups.
Dietary cholesterol mass absorbed (calculated by multiplying the
fractional absorption with total cholesterol intake) was also
significantly lower in the 18:0 group compared to the other treatment
groups. Consequently, the mass of dietary cholesterol not absorbed was
significantly higher in the 18:0 group. Endogenous cholesterol
excretion was then calculated by subtracting the amount of unabsorbed
dietary cholesterol from total neutral steroids in the feces.
Endogenous cholesterol excretion was significantly higher in hamsters
fed the high 18:0 diet compared to the other treatment groups. Thus,
total cholesterol turnover (endogenous cholesterol + bile acid
excretion) was about 100% higher in the 18:0 group (11 µmol x d-1 x 100 g body
wt-1) compared to the other treatment groups
(56 µmol x d-1 x 100 g body
wt-1).
|
| DISCUSSION |
|---|
|
|
|---|
We included 18:1t in the study design because of the recent
claim that consumption of trans fatty acids causes
30,000150,000 deaths each year from heart disease (Food Chemical News 1994
, Willett and Ascherio 1994
).
Contrary to our initial hypothesis, dietary 18:1t was not
hypercholesterolemic, and no significant differences were observed in
cholesterol absorption efficiency or cholesterol turnover in the
18:1t group compared with hamsters fed diets enriched in
16:0, 18:1c and 18:2. Nicolosi et al. (1998)
also reported no difference in plasma cholesterol concentration between
hamsters fed diets enriched in 18:1t and 18:1c.
In contrast, dietary 18:0 in the present study resulted in lower plasma
cholesterol concentrations, significantly reduced cholesterol
absorption and increased cholesterol turnover compared to the other
treatment groups.
The increased cholesterol turnover in hamsters fed the high 18:0 diet
was primarily due to increased fecal excretion of endogenous
cholesterol. Although bile acid excretion was increased in the 18:0
group, endogenous cholesterol excretion accounted for 8088% of total
steroid output by the body. Imaizumi et al. (1993)
also
reported increased excretion of endogenous cholesterol in hamsters fed
cholesterol-free diets enriched in 18:0 compared to diets high in
16:0, myristic (14:0) and lauric (12:0) acids. As in our study, bile
acid output represented only 1025% of total steroid excretion
(Imaizumi et al. 1993
). Addition of 0.2% cholesterol to
the same fatty acid-enriched diets also resulted in increased
neutral steroid excretion, but the contribution of unabsorbed dietary
cholesterol to total fecal neutral steroids was not determined
(Imaizumi et al. 1993
). A similar finding was reported
in rats fed cholesterol-free diets; fecal cholesterol excretion was
increased in rats fed high 18:0 compared to 16:0 (Kamei et al. 1995
). Bile acid excretion in the rats constituted a higher
proportion of total steroid output than in hamsters (about 40% of
total fecal steroids in the rat study), although no treatment
differences in bile acid excretion were detected (Kamei et al. 1995
).
Whether dietary 18:0 increases endogenous cholesterol excretion in
humans is uncertain. Historically, sterol balance studies in humans
were designed to compare "saturated" (e.g., coconut oil, butter)
vs. "polyunsaturated" fats (e.g., corn oil, safflower oil) rather
than isolating the effects of individual dietary fatty acids. While not
all of the early sterol balance studies showed treatment effects,
several studies demonstrated an increase in neutral steroid excretion
when polyunsaturated fats replaced saturated fatty acids in the diet
(Antonis and Bersohn 1962
, Connor et al. 1969
, Grundy 1975
, Moore et al. 1968
, Nestel et al. 1973
and 1975
,
Shepherd et al. 1980
). In the study of Connor et al. (1969)
, corn oil was used as the polyunsaturated fat and
cocoa butter as the saturated fat source. Although cocoa butter
contains about 35% 18:0, it also contains 2526% 16:0. The multiple
fatty acid differences in the plant oils used by Connor et al. (1969)
did not allow the investigators to isolate the
contribution of dietary 18:0 to endogenous steroid excretion.
Hamsters fed the high 18:0 diet had lower body weights than hamsters in
the other treatment groups despite similar food intakes. To account for
the differences in body weight, the sterol balance data in this report
have been normalized to 100 g body weight. Kamei et al. (1995)
also reported that hamsters fed diets high in 18:0
compared to 16:0 had decreased body weight gain. Nicolosi et al. (1998)
reported decreased body weight gain and feed efficiency
in hamsters fed diets enriched with 18:0 compared to caprylic acid
(8:0), 14:0, 18:1c and 18:1t. In both studies
(Kamei et al. 1995
, Nicolosi et al. 1998
), as in the current study, lipid absorption was also
decreased in animals consuming 18:0 enriched diets. The present data
suggest that decreased absorption of total energy from fat may account
for the decrease in body weight in hamsters fed the high 18:0 diet. A
significant correlation (r = 0.79, P < 0.001) was observed between the amount of dietary lipid absorbed (Table 4)
and body weight (Table 3)
when individual animal data points were
plotted. A correlation of the means of lipid absorption and body weight
showed a stronger correlation (r = 0.99, P
< 0.001). These data, however, do not exclude the possibility
that the high 18:0 diet may have limited the absorption of other
nutrients necessary for optimal growth.
Reduced cholesterol absorption in the 18:0 group likely contributed to
the significant increase in endogenous cholesterol excretion. Studies
in lymph duct cannulated rats fed 18:0-enriched diets showed a
significant reduction in cholesterol absorption (Chen et al. 1989
, Ikeda et al. 1994
). Using three different
methods to measure cholesterol absorption (i.e., plasma isotope ratio
method, fecal dual isotope method and lymph duct cannulation),
Feldman et al. (1979a
and 1979b
) clearly documented
reduced cholesterol absorption in rats fed 18:0. We were unable to find
a human study that examined the specific effect of dietary 18:0 on
cholesterol absorption. Nevertheless, the present study in hamsters
provides evidence in a species other than rats that dietary 18:0
inhibits cholesterol absorption.
Schmidt and Gallaher (1997)
suggested in a recent
abstract that dietary 18:0 decreased cholesterol solubilization in the
small intestine. We speculate that dietary 18:0 inhibits cholesterol
absorption by interfering with micelle formation. Disrupted micelle
formation could occur by several possible mechanisms. First, because
18:0 is a straight, long-chain fatty acid, its physical presence in
the small intestine may impart micellar instability. However,
18:1t is similar to 18:0 in physical dimension but did not
reduce cholesterol absorption in the present study, so this possibility
seems unlikely. Second, dietary 18:0 incorporation into hepatic and
biliary phospholipids could alter micelle formation. Wang and Koo (1993a
and 1993b
) showed that 18:0 delivered to the liver
was preferentially incorporated into phospholipids. Cohen and Carey (1991)
reported that micelle stability and cholesterol
solubility were reduced when micellar phospholipids contained 18:0
compared to unsaturated fatty acids. Third, dietary 18:0 incorporated
into the liver could alter the bile acid profile and, consequently, the
ability to solubilize cholesterol. Hassel et al. (1997)
recently reported that dietary 18:0, relative to 16:0, significantly
altered the fecal bile acid composition in hamsters. Preliminary data
in our laboratory (Carr, T. P., unpublished observations) further
indicate that dietary 18:0 alters the bile acid profile and thus
decreases the "hydrophobicity index" (Heuman 1989
)
of the bile. A reduced hydrophobicity index of bile would presumably
decrease cholesterol solubility and absorption. Fourth, the
stereospecific composition of the dietary triacylglycerol molecules may
also influence micelle formation. Sheanut oil and cocoa butter were
used in this study as major sources of dietary 18:0. The
triacylglycerol molecules present in cocoa butter and, presumably,
sheanut oil contain 18:0 mainly in the external (sn-1 and
sn-3) positions (Small 1991
). The free 18:0
liberated during digestion is absorbed to a lesser extent than other
common dietary fatty acids (reviewed by Bracco 1994
),
suggesting a decreased ability of free 18:0 to form stable micelles.
Our current data (Table 4)
also indicate lower 18:0 absorption. It is
presumed that the high melting temperature of 18:0 contributes to its
decreased solubility and absorbability (Small 1991
).
Consequently, impaired micelle formation due to the presence of dietary
18:0 would also inhibit the absorption of cholesterol in the small
intestine.
Finally, it is important to discuss how cholesterol absorption and
turnover might be related to plasma cholesterol concentration. The
hypocholesterolemic effect of dietary 18:0 in humans is well documented
(reviewed by Grundy 1994
), and the plasma cholesterol
concentration in the present study was lowest in hamsters fed
18:0-enriched diets. This finding appears to be attributable, at least
in part, to the increased excretion of endogenous cholesterol.
Increased cholesterol output by the liver could lead to decreased
hepatic cholesterol concentrations. Studies have shown decreased liver
cholesterol concentration in hamsters fed diets high in 18:0 relative
to 16:0, 14:0 and 12:0 (Hassel et al. 1997
,
Imaizumi et al. 1993
). We have also observed reduced
liver cholesterol concentration in hamsters fed 18:0 (Carr, T. P.,
unpublished observations). Brown and Goldstein (1986)
clearly documented that reduced liver cholesterol concentration leads
to increased clearance of plasma LDL cholesterol via LDL receptors.
Woollett et al. (1992)
reported that hamsters fed 18:0,
relative to 16:0, had significantly increased hepatic LDL receptor
activity and decreased plasma LDL cholesterol concentration. Although
LDL receptor activity was not measured in the present study, the data
suggest that reduced plasma cholesterol concentration in hamsters fed
high 18:0 diets may be influenced by reduced cholesterol absorption and
increased excretion of endogenous cholesterol.
| FOOTNOTES |
|---|
2 Presented in part at Experimental Biology 98
[Schneider, C. L. and Carr, T. P. (1998) Dietary stearic
acid reduces cholesterol absorption in hamsters. FASEB J. 12: A562]. ![]()
4 Abbreviations used: 12:0, lauric acid; 14:0,
myristic acid; 16:0, palmitic acid; 18:0, stearic acid;
18:1t, trans fatty acids;
18:1c, cis oleic acid; 18:2, linoleic
acid. ![]()
Manuscript received August 12, 1999. Initial review completed November 1, 1999. Revision accepted January 10, 2000.
| REFERENCES |
|---|
|
|
|---|
1. Ahrens E. H. Jr, Hirsch J., Insull W., Tsaltas T. T., Blomstrand R., Peterson M. L. The influence of dietary fats on serum-lipid levels in man. Lancet 1957;1:943-953
2. American Institute of Nutrition Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J. Nutr. 1977;107:1340-1348
3. Antonis A., Bersohn I. The influence of diet on fecal lipids in South African white and Bantu prisoners. Am. J. Clin. Nutr. 1962;11:142-155[Abstract]
4. Borgström B. Quantification aspects of the intestinal absorption and metabolism of cholesterol and ß-sitosterol in the rat. J. Lipid Res. 1968;9:473-481[Abstract]
5.
Bracco U. Effect of triglyceride structure on fat absorption. Am. J. Clin. Nutr. 1994;60(suppl):1002S-1009S
6.
Brown M. S., Goldstein J. L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47
7. Cai G., Carr T. P. Biliary cholesterol and bile acid excretion do not increase in hamsters fed cereal-based diets containing cholesterol. Metabolism 1999;48:400-405[Medline]
8. Carr T. P., Andersen C. J., Rudel L. L. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 1993;26:39-42[Medline]
9. Chen I. S., Subramaniam S., Vahouny G. V., Cassidy M. M., Ikeda I., Kritchevsky D. A comparison of the digestion and absorption of cocoa butter and palm kernel oils and their effects on cholesterol absorption in rats. J. Nutr. 1989;119:1569-1573
10. Cohen D. E., Carey M. C. Acyl chain unsaturation modulates distribution of lecithin molecular species between mixed micelles and vesicles in model bile. Implications for particle structure and metastable cholesterol solubilities. J. Lipid Res. 1991;32:1291-1302[Abstract]
11. Connor W. E., Witiak D. T., Stone D. B., Armstrong M. L. Cholesterol balance and fecal neutral steroid and bile acid excretion in normal men fed dietary fats of different fatty acid composition. J. Clin. Invest. 1969;48:1363-1375
12. Feldman E. B., Russell B. S., Schnare F. H., Miles B. C., Doyle E. A., Moretti-Rojas I. Effect of tristearin, triolein and safflower oil diets on cholesterol balance in rats. J. Nutr. 1979a;109:2226-2236
13. Feldman E. B., Russell B. S., Schnare F. H., Moretti-Rojas I., Miles B. C., Doyle E. A. Effect of diets of homogenous saturated triglycerides on cholesterol balance in rats. J. Nutr. 1979b;109:2237-2246
14. Folch J., Lees M., Sloane Stanley G. H. A simple method for the isolation and purification of total lipids form animal tissues. J. Biol. Chem. 1957;224:497-509
15. Food Chemical News. Willett, Shapiro debate trans fatty acid issue at tox forum. July 25: 2631
16. Grundy S. M. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia. J. Clin. Invest. 1975;55:269-282
17.
Grundy S. M. Influence of stearic acid on cholesterol metabolism relative to other long-chain fatty acids. Am. J. Clin. Nutr. 1994;60(suppl):986S-990S
18.
Hassel C. A., Mensing E. A., Gallaher D. D. Dietary stearic acid reduces plasma and hepatic cholesterol concentrations without increasing bile acid excretion in cholesterol-fed hamsters. J. Nutr. 1997;127:1148-1155
19. Hegsted D. M., McGandy R. B., Myers M. L., Stare F. J. Quantitative effects of dietary fat on serum cholesterol in man. Am. J. Clin. Nutr. 1965;17:281-295[Medline]
20. Heuman D. M. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J. Lipid Res. 1989;30:719-730[Abstract]
21. Ikeda I., Imasato Y., Nakayama M., Imaizumi K., Sugano M. Lymphatic transport of stearic acid and its effect on cholesterol transport in rats. J. Nutr. Sci. Vitaminol. 1994;40:275-282
22. Imaizumi K., Abe K., Kuroiwa C., Sugano M. Fat containing stearic acid increases fecal neutral steroid excretion and catabolism of low density lipoproteins without affecting plasma cholesterol concentration in hamsters fed a cholesterol-containing diet. J. Nutr. 1993;123:1693-1702
23. Kamei M., Ohgaki S., Kanbe T., Niiya I., Mizutani H., Matsui-Yuasa I., Otani S., Morita S. Effects of highly hydrogenated soybean oil and cholesterol on plasma, liver cholesterol, and fecal steroids in rats. Lipids 1995;30:533-539[Medline]
24. Keys A., Anderson J. T., Grande F. Serum cholesterol response to changes in the diet. IV. Particular saturated fatty acids in the diet. Metabolism 1965;14:776-787
25. Knapka J. J., Smith K. P., Judge F. J. Effect of open and closed formula rations on the performance of three strains of laboratory mice. Lab. Anim. Sci. 1974;24:480-487[Medline]
26. Metcalfe L. D., Schmitz A. A., Pelka J. R. Rapid preparation of fatty acid esters from lipids for gas chromatographic analysis. Anal. Chem. 1966;38:514-515
27. Moore R. B., Anderson J. T., Taylor H. L., Key A., Frantz I. D. Jr Effect of dietary fat on the fecal excretion of cholesterol and its degradation products in man. J. Clin. Invest. 1968;47:1517-1534
28. Nestel P. J., Havenstein N., Homma Y., Scott T. W., Cook L. J. Increased sterol excretion with polyunsaturated-fat high-cholesterol diets. Metabolism 1975;24:189-198[Medline]
29. Nestel P. J., Havenstein N., Malcolm Whyte H., Scott T. J., Cook L. J. Lowering of plasma cholesterol and enhanced sterol excretion with the consumption of polyunsaturated ruminant fats. N. Engl. J. Med. 1973;288:379-382
30.
Nicolosi R. J., Wilson T. A., Rogers E. J., Kritchevsky D. Effects of specific fatty acids (8:0, 14:0, cis-18:1, trans-18:1) on plasma lipoproteins, early atherogenic potential, and LDL oxidative properties in the hamster. J. Lipid Res. 1998;39:1972-1980
31. Schmidt K., Gallaher D. Reduced cholesterol absorption and intestinal solubilization by stearic acid-rich fats in rats. FASEB J 1997;11:A378
32. Shepherd J., Packard C. J., Grundy S. M., Yeshurun D., Gotto A. M., Jr & Taunton O. D. Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J. Lipid Res. 1980;21:91-99[Abstract]
33. Small D. M. The effects of glyceride structure on absorption and metabolism. Annu. Rev. Nutr. 1991;11:413-434[Medline]
34. Turley S. D., Daggy B. P., Dietschy J. M. Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liver. Gastroenterology 1994;107:444-452[Medline]
35. Ueda T., Igarashi O. New solvent system for extraction of tocopherols from biological specimens for HPLC determination and the evaluation of 2,2,5,7,8-pentamethyl-6-chromanol as an internal standard. J. Micronutrient Anal. 1987;3:185-198
36. Wang S., Koo S. I. Evidence for distinct metabolic utilization of stearic acid in comparison with palmitic and oleic acids in rats. J. Nutr. Biochem. 1993a;4:594-601
37. Wang S., Koo S. I. Plasma clearance and hepatic utilization of stearic, myristic and linoleic acids introduced via chylomicrons in rats. Lipids 1993b;28:697-703[Medline]
38.
Willett W. C., Ascherio A. Trans fatty acids: Are the effects only marginal?. Am. J. Pub. Health 1994;84:722-724
39. Woollett L. A., Spady D. K., Dietschy J. M. Regulatory effects of the saturated fatty acids 6:0 through 18:0 on hepatic low density lipoprotein receptor activity in the hamster. J. Clin. Invest. 1992;89:1133-1141
This article has been cited by other articles:
![]() |
H. E. Rasmussen, D. M. Guderian Jr., C. A. Wray, P. H. Dussault, V. L. Schlegel, and T. P. Carr Reduction in Cholesterol Absorption Is Enhanced by Stearate-Enriched Plant Sterol Esters in Hamsters J. Nutr., November 1, 2006; 136(11): 2722 - 2727. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Carr, C. L. Weller, V. L. Schlegel, S. L. Cuppett, D. M. Guderian Jr., and K. R. Johnson Grain Sorghum Lipid Extract Reduces Cholesterol Absorption and Plasma Non-HDL Cholesterol Concentration in Hamsters J. Nutr., September 1, 2005; 135(9): 2236 - 2240. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Lee and T. P. Carr Dietary Fatty Acids Regulate Acyl-CoA:Cholesterol Acyltransferase and Cytosolic Cholesteryl Ester Hydrolase in Hamsters J. Nutr., December 1, 2004; 134(12): 3239 - 3244. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kishida, S. Miyazato, H. Ogawa, and K. Ebihara Taurine Prevents Hypercholesterolemia in Ovariectomized Rats Fed Corn Oil but Not in Those Fed Coconut Oil J. Nutr., August 1, 2003; 133(8): 2616 - 2621. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Treadwell, A. Pronczuk, and K. C. Hayes Glyceride Stearic Acid Content and Structure Affect the Energy Available to Growing Rats J. Nutr., November 1, 2002; 132(11): 3356 - 3362. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Gallaher, C. M. Gallaher, G. J. Mahrt, T. P. Carr, C. H. Hollingshead, R. Hesslink Jr, and J. Wise A Glucomannan and Chitosan Fiber Supplement Decreases Plasma Cholesterol and Increases Cholesterol Excretion in Overweight Normocholesterolemic Humans J. Am. Coll. Nutr., October 1, 2002; 21(5): 428 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Cowles, J.-Y. Lee, D. D. Gallaher, C. L. Stuefer-Powell, and T. P. Carr Dietary Stearic Acid Alters Gallbladder Bile Acid Composition in Hamsters Fed Cereal-Based Diets J. Nutr., October 1, 2002; 132(10): 3119 - 3122. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jiang, S. K. Noh, and S. I. Koo Egg Phosphatidylcholine Decreases the Lymphatic Absorption of Cholesterol in Rats J. Nutr., September 1, 2001; 131(9): 2358 - 2363. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||